mFluor™ UV375 Anti-human CD158d Antibody *mAb#33*
The mAb#33 monoclonal antibody binds to human CD158d, a 45 - 50 kD transmembrane glycoprotein frequently expressed on the surface of natural killer cells. In certain organisms, CD158d negatively regulates natural killer cell mediated cytotoxicity, is an enhancer of cellular senescence and positively regulates natural killer cell cytokine production. From a research standpoint, it is of biological interest due to its association with essential macromolecules/ligands like HLA-Bw4. CD158d is a relatively rare antibody target, with fewer than 200 publications in the last decade. Even still, CD158d has been widely used in immunology and innate immunity research, often serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to mFluor™ UV375 (ex/em = 351/387 nm). It is compatible with the 355 nm laser and 379/28 nm bandpass filter (for example, as in the BD FACSymphony™ A5).
Spectrum
Open in Advanced Spectrum Viewer
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of cd158d antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on October 31, 2024